Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Peripheral Nervous System Diseases 1 Pancreatic Neoplasms 1 Lymphangioleiomyomatosis 1 Breast Neoplasms 1

Interventions

Sirolimus 2 temsirolimus 1 saracatinib 1 Valproic Acid 1 Immunoglobulin G 1 Imatinib Mesylate 1 Hydroxychloroquine 1 Glutamine 1 Disulfides 1 Cetuximab 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Lymphangioleiomyomatosis × Glutamine × Clear all

NCT04388371 2021-08-11

Glutamine PET Imaging in LAM

Vanderbilt University Medical Center

Phase 1 Completed

Lymphangioleiomyomatosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡